Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands

This publication has 36 references indexed in Scilit:

• Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
  Diabetes Epidemiology and Management, 2023
• Socioeconomic aspects of incretin-based therapy
  Diabetologia, 2023
• Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
  PharmacoEconomics, 2023
• The introduction of a data-driven population health management approach in the Netherlands since 2019: The Extramural LUMC Academic Network data infrastructure
  Health Policy, 2023
• Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
  JAMA Network Open, 2021
• Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
  JAMA Network Open, 2021
• Population Health Management for Diabetes: Health Care System-Level Approaches for Improving Quality and Addressing Disparities
  Current Diabetes Reports, 2017
• Understanding Population Health Through Diabetes Population Management
  Endocrinology and Metabolism Clinics of North America, 2016
• A Markov chain Monte Carlo algorithm for multiple imputation in large surveys
  AStA Advances in Statistical Analysis, 2008
• A new drug classification for computer systems: the ATC extension code
  International Journal of Bio-Medical Computing, 1995